Blog - Page 4124 of 5438

MondayNov 03, 2008 4:43 am

Blue Note Mining (TSX: BN)

Blue Note Mining (TSX: BN CN) was founded with the purpose of taking advantage of Canadian metals mining opportunities. The company’s first asset acquisition was the Caribou and Restigouche lead-zinc mines located near Bathurst, New Brunswick. Blue Note intends to make other corporate and asset acquisitions in the near term future. Their exploration strategy is focused on providing a continuous source of sulphide ore feed for the concentrator at the Caribou mine/mill complex. For further information, visit the Company's web site at www.bluenotemining.ca.

MondayNov 03, 2008 4:43 am

OXiGENE, Inc. (NASDAQ: OXGN)

OXiGENE, Inc. (NASDAQ: OXGN), a biopharmaceutical company, is focused on finding and developing new and improved therapeutics that attend to the substantial, but unmet needs of patients diagnosed with cancer and eye disease. The company’s primary focus is on the development and commercialization of first-in-class and best-in-class vascular disrupting agents (VDAs) designed to treat cancer and eye disease. To date, OXiGENE's VDA product candidates have shown considerable potential in human clinical studies. For further information, visit the Company's web site at www.oxigene.com.

MondayNov 03, 2008 4:42 am

Osteologix, Inc. (OTC BB: OLGX)

Osteologix, Inc. (OTC BB: OLGX), a specialty biopharmaceutical company, has dedicated their efforts to improving the health of those afflicted with musculoskeletal diseases through the development of innovative therapies. NB S101, the company’s lead investigational product candidate, is an innovative pharmaceutical agent designed to treat and prevent osteoporosis. Their mission is to partner with the healthcare community to apply new scientific information to the development of beneficial products. For more information please visit www.osteologix.com.

MondayNov 03, 2008 4:42 am

BioSphere Medical, Inc. (NASDAQ: BSMD)

BioSphere Medical, Inc. (NASDAQ: BSMD) is focused on applying their proprietary microsphere technology to medical applications through the use of embolotherapy techniques. The company’s core technologies consist of patented bio-engineered polymers and manufacturing methods, which are used to produce miniature spherical beads with uniquely beneficial properties for a variety of medical applications. For further information, visit the Company's web site at www.equityny.com.

MondayNov 03, 2008 4:42 am

Osiris Therapeutics, Inc. (NASDAQ: OSIR)

Osiris Therapeutics, Inc. (NASDAQ: OSIR), a leading stem cell therapeutic company, has their focus on developing and marketing products for the treatment of medical conditions in the inflammatory, orthopedic, and cardiovascular areas. The company’s stem cell products have major therapeutic potential because of their ability to promote tissue regeneration, regulate inflammation and prevent pathological scar formation. For further information, visit the Company's web site at www.osiris.com.

MondayNov 03, 2008 4:41 am

Oscient Pharmaceuticals Corporation (NASDAQ: OSCI)

Oscient Pharmaceuticals Corporation (NASDAQ: OSCI), a commercial-stage pharmaceutical company, is devoted to marketing two FDA-approved products in the United States: ANTARA® capsules, a cardiovascular product; and FACTIVE® tablets, a fluoroquinolone antibiotic. ANTARA is designed to treat hypercholesterolemia (high blood cholesterol) and hypertriglyceridemia (high triglycerides) in combination with diet. FACTIVE is designed to treat acute bacterial exacerbations of chronic bronchitis and pneumonia. For further information, visit the Company's web site at www.oscient.com.

MondayNov 03, 2008 4:41 am

BioSpecifics Technologies Corp. (OTC BB: BSTC)

BioSpecifics Technologies Corp. (OTC BB: BSTC), a biopharmaceutical company, has developed and licensed injectable collagenase for three clinical indications. Their development and licensing agreement with Auxilium Pharmaceuticals (Nasdaq GM: AUXL) is for clinical indications in Dupuytren’s disease, Peyronie’s disease and frozen shoulder (adhesive capsulitis). Currently, all of their efforts are focused on the future development and commercialization of injectable collagenase products. For further information, visit the Company's web site at www.biospecifics.com.

MondayNov 03, 2008 4:41 am

Orthovita, Inc. (NASDAQ: VITA)

Orthovita, Inc. (NASDAQ: VITA), a novel spine/orthopaedic surgical biomaterials company, is focused on providing progressive bone regeneration and soft tissue healing technologies. The company’s expertise lies in developing and distributing novel, high-tech, synthetic-based biomaterial products. Currently, Orthovita has several key commercial product platforms including: Vitoss Bone Graft Substitute, Vitagel Surgical Hemostat, Cortoss Synthetic Cortical Bone, and Imbibe Delivery and Disposable Systems. For further information, visit the Company's web site at www.orthovita.com.

MondayNov 03, 2008 4:40 am

BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX)

BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), a specialty pharmaceutical company, is committed to developing products for female sexual health, menopause, contraception and male hypogonadism. Lead products within their produce line include LibiGel® (transdermal testosterone gel), which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) SPA (Special Protocol Assessment); and Elestrin™ (estradiol gel) which has been developed through FDA approval. For further information, visit the Company's web site at www.biosantepharma.com.

MondayNov 03, 2008 4:40 am

Origin Agritech Limited (NASDAQ: SEED)

Origin Agritech Limited (NASDAQ: SEED), a leading agricultural biotechnology company and a top player in seed industry, specializes in researching and developing, producing, selling and distributing agricultural crop seeds. The Company's major seed products are corn, rice, cotton and canola. Located in Beijing, China, the company is focused on crop improvement and utilizes biotechnology to achieve their goals. For further information, visit the company website at: www.originagritech.com.

Site Search

Company Search

Blue Note Mining (TSX: BN)

OXiGENE, Inc. (NASDAQ: OXGN)

Osteologix, Inc. (OTC BB: OLGX)

BioSphere Medical, Inc. (NASDAQ: BSMD)

Osiris Therapeutics, Inc. (NASDAQ: OSIR)

Oscient Pharmaceuticals Corporation (NASDAQ: OSCI)

BioSpecifics Technologies Corp. (OTC BB: BSTC)

Orthovita, Inc. (NASDAQ: VITA)

BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX)

Origin Agritech Limited (NASDAQ: SEED)

Market Basics

Newsletter Publishers

Public Companies